Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat vs Darbepoetin Alfa in Hemodialysis CKD Anemia (Japan)
NCT02952092Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by Astellas Pharma. Started Nov 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02952092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02952092.